Teva Loses Challenge Of €60M Pay-For-Delay Fine
A European court on Wednesday rejected an appeal from Teva and its subsidiary Cephalon seeking to nix more than €60 million ($63.2 million) in fines for allegedly conspiring with one another...To view the full article, register now.
Already a subscriber? Click here to view full article